Tumor cells have developed adaptive immune resistance to avoid antitumor immune responses, which relies on PD-L1 expression stimulated by inflammatory signals such as interferon gamma (IFN-γ) secreted by activated tumor-infiltrating cells [24,25]. Here, CD274 is linked to neoplasm.